Vidyalakshmi Chandramohan

Person

Durham, NC, US

People

Patents Grantslast 30 patents

Information Patent Grant
Detection of CD-155, the poliovirus receptor
- Patent number 11,506,666
- Issue date Nov 22, 2022
- Duke University
- Darell D. Bigner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Production of immunotoxin D2C7—(scdsFv)—PE38KDEL
- Patent number 11,311,628
- Issue date Apr 26, 2022
- Duke University
- Darell D. Bigner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of immunotoxin and checkpoint inhibitor
- Patent number 11,065,332
- Issue date Jul 20, 2021
- Duke University
- Darell Bigner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination treatment
- Patent number 10,744,170
- Issue date Aug 18, 2020
- Duke University
- Darell D. Bigner
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Combination Therapy of Immunotoxin and Checkpoint Inhibitor
- Publication number 20240350624
- Publication date Oct 24, 2024
- DUKE UNIVERSITY
- Darell Bigner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN
- Publication number 20230141413
- Publication date May 11, 2023
- DUKE UNIVERSITY
- Darell BIGNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapy of Immunotoxin and Checkpoint Inhibitor
- Publication number 20210338811
- Publication date Nov 4, 2021
- DUKE UNIVERSITY
- Darell Bigner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DETECTION OF CD-155, THE POLIOVIRUS RECEPTOR
- Publication number 20210311063
- Publication date Oct 7, 2021
- DUKE UNIVERSITY
- Darell D. Bigner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEOADJUVANT CANCER TREATMENT WITH IMMUNOTOXIN AND CHECKPOINT INHIBI...
- Publication number 20210214442
- Publication date Jul 15, 2021
- DUKE UNIVERSITY
- Darell BIGNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Treatment
- Publication number 20200368300
- Publication date Nov 26, 2020
- DUKE UNIVERSITY
- Darell D. Bigner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Production of Immunotoxin D2C7 - (scdsFv) -PE38KDEL
- Publication number 20200046847
- Publication date Feb 13, 2020
- DUKE UNIVERSITY
- Darell D. Bigner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY OF IMMUNOTOXIN AND CHECKPOINT INHIBITOR
- Publication number 20180311346
- Publication date Nov 1, 2018
- DUKE UNIVERSITY
- Darell Bigner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Treatment
- Publication number 20180296614
- Publication date Oct 18, 2018
- DUKE UNIVERSITY
- Darell D. Bigner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Anti-Podoplanin Antibodies and Methods of Use
- Publication number 20150368353
- Publication date Dec 24, 2015
- DUKE UNIVERSITY
- Darell BIGNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PODOPLANIN ANTIBODIES AND METHODS OF USE
- Publication number 20140017266
- Publication date Jan 16, 2014
- THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF HHS, NIH
- Darell Bigner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Vidyalakshmi Chandramohan

Person

Patents Grantslast 30 patents

Detection of CD-155, the poliovirus receptor

Production of immunotoxin D2C7—(scdsFv)—PE38KDEL

Combination therapy of immunotoxin and checkpoint inhibitor

Combination treatment

Patents Applicationslast 30 patents

Combination Therapy of Immunotoxin and Checkpoint Inhibitor

IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN

Combination Therapy of Immunotoxin and Checkpoint Inhibitor

DETECTION OF CD-155, THE POLIOVIRUS RECEPTOR

NEOADJUVANT CANCER TREATMENT WITH IMMUNOTOXIN AND CHECKPOINT INHIBI...

Combination Treatment

Production of Immunotoxin D2C7 - (scdsFv) -PE38KDEL

COMBINATION THERAPY OF IMMUNOTOXIN AND CHECKPOINT INHIBITOR

Combination Treatment

Anti-Podoplanin Antibodies and Methods of Use

ANTI-PODOPLANIN ANTIBODIES AND METHODS OF USE